HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ferric pyrophosphate

Also Known As:
Actiferol Fe; JM-3100; Sunactive Fe; ferric pyrophosphate nonahydrate
Networked: 21 relevant articles (3 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hurrell, Richard F: 6 articles (07/2017 - 10/2004)
2. Zimmermann, Michael B: 6 articles (07/2017 - 10/2004)
3. Zeder, Christophe: 3 articles (04/2011 - 10/2004)
4. Fang, Yi: 2 articles (09/2022 - 06/2022)
5. Gan, Liangying: 2 articles (09/2022 - 06/2022)
6. Hui, Ai-Min: 2 articles (09/2022 - 06/2022)
7. Li, Kexin: 2 articles (09/2022 - 06/2022)
8. Pratt, Raymond: 2 articles (09/2022 - 06/2022)
9. Tan, Yan: 2 articles (09/2022 - 06/2022)
10. Wei, Gang: 2 articles (09/2022 - 06/2022)

Related Diseases

1. Malaria
2. Iron Deficiencies
3. Inflammation (Inflammations)
4. Iron-Deficiency Anemia (Anemia, Iron Deficiency)
03/01/2013 - "Iontophoretic mediated transdermal delivery of ferric pyrophosphate (FPP) in combination with microneedle pretreatment was investigated as a potential treatment for iron deficiency anemia (IDA). "
01/01/2018 - "Effects of micronised dispersible ferric pyrophosphate combined with alpha-lactalbumin in pregnant women affected by iron deficiency anemia: results from a prospective, double-blind, randomized controlled trial."
01/01/2018 - "This study aimed at evaluating the effects obtained by administering 30 mg of micronised dispersible ferric pyrophosphate plus 300 mg of alpha-lactalbumin (MDFP-AL) compared to 80 mg of ferrous gluconate (FG) in pregnant women affected by iron-deficiency anemia (IDA). "
07/14/2017 - "Iron Fortified Complementary Foods Containing a Mixture of Sodium Iron EDTA with Either Ferrous Fumarate or Ferric Pyrophosphate Reduce Iron Deficiency Anemia in 12- to 36-Month-Old Children in a Malaria Endemic Setting: A Secondary Analysis of a Cluster-Randomized Controlled Trial."
01/01/2018 - "We conducted a systematic review and meta-analysis from randomized and quasi-randomized controlled trials to 1) assess the effect of DFS on biomarkers of iron status and the risk of anemia and iron deficiency anemia (IDA) and 2) evaluate differential effects of DFS by study type (efficacy or effectiveness), population subgroups, iron formulation (ferrous sulfate, ferrous fumarate, and ferric pyrophosphate), iron concentration, duration of intervention, and study quality. "
5. Anemia

Related Drugs and Biologics

1. ferrous fumarate (fumar)
2. Fe(III)-EDTA (Sytron)
3. Hepcidins
4. Biomarkers (Surrogate Marker)
5. Citric Acid (Citrate)
6. Transferrin (beta 2 Transferrin)
7. Salts
8. Iodine
9. Iron
10. ferrous sulfate

Related Therapies and Procedures

1. Renal Dialysis (Hemodialysis)